Need Help?
Contact Us


Register for Boston Scientific’s symposia to hear from peers and therapy leaders as they discuss the evolving clinical landscape. Learn about next-generation TAVR, how to optimize PCI though advancements in coronary physiology and high-definition IVUS, and how the SENTINEL™ Cerebral Protection System represents a paradigm shift towards standard of care.

LOTUS Edge™, ACURATE neo2™, and the SENTINEL™ Cerebral Protection System: Next-Generation TAVR

Chair and Moderator: Dr. Ted Feldman

  • The Ulm University Experience with the SENTINEL CPS
  • SENTINEL CPS: A “Real-World” Experience
  • LOTUS Edge: Cutting “Edge” Experience
  • ACURATE neo2: Building the Evidence
  • The Future Clinical Trial Landscape of TAVR
  • Panel Discussion   

Saturday, September 22nd
Presentation Theater 4
11:30-12:30 p.m.

Optimizing PCI: New Options in Coronary Physiology and High-Definition IVUS

Chair and Moderator: Morton J. Kern, MD

  • Coronary Physiology Toolbox -- Morton J. Kern, MD
  • DFR Methodology & Analysis -- Nils P. Johnson, MD, MS
  • When to Use What in Coronary Physiology -- Ziad A. Ali, MD, DPhil
  • HD IVUS - When Precision & Depth Matter -- Akiko Maehara, MD
  • Panel discussion
    • Moderator: Morton J. Kern, MD
    • Discussants: Nils P. Johnson, MD, MS; Ziad A. Ali, MD, DPhil; Akiko Maehara, MD

Sunday, September 23rd
Presentation Theater 4
1:00-2:00 p.m.

Cerebral Embolic Protection with SENTINEL™ in TAVR
A paradigm shift toward standard of care

  • Impact of CEP in practice: Ease of cath-lab integration & the associated real-world clinical outcomes
  • Stroke Happens. Protection Works—A contemporary review of the data supporting the use of the SENTINEL CPS in TAVR
  • Stroke economics & the role of the SENTINEL CPS in building referral pathways to grow your TAVR program
  • The role of cerebal protection in the age of minimalism  
  • Considerations for the future of CEP: Implications of the TAVR consensus statement for stroke reporting and the role of shared decision making
  • Panel Discussion

Monday, September 24th
Presentation Theater 3
11:30-12:30 p.m.